Clear Cell Ependymoma Active Not Recruiting Phase 3 Trials for Vincristine (DB00541)

IndicationStatusPhase
DBCOND0086684 (Clear Cell Ependymoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01096368Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed EpendymomaTreatment